Role of conventional therapies in the era of biological treatment in Crohn&rsquo;s disease

doi:10.3748/wjg.v17.i14.1797

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3733)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

422

HTML

3055

Figures (1-1)

256

Sum=3733

Apr 14, 2011 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 14, 2011; 17(14): 1797-1806
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1797

Open in New Tab Full Size Figure Download Figure

Figure 1 Treatment Algorithms. EIMs: Extraintestinal manifestations; SASP: Sulfasalazine; 5- ASA: Five-aminosalicylic acid; AZA: Azathioprine; MTX: Methotrexate.

Citation: Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, Fornarini GS, Riso D, Campieri M, Rizzello F. Role of conventional therapies in the era of biological treatment in Crohn’s disease. World J Gastroenterol 2011; 17(14): 1797-1806
URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1797.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1797